Clinical Trial of Cryotherapy Versus Postoperative Laser Photocoagulation
Rhegmatogenous Retinal Detachment
About this trial
This is an interventional treatment trial for Rhegmatogenous Retinal Detachment focused on measuring rhegmatogenous retinal detachment, cryopexy, photocoagulation
Eligibility Criteria
Inclusion Criteria:
- Primary rhegmatogenous retinal detachment with a single peripherical retinal break. All patients were phakic, under eighteen years old, with partial posterior vitreous detachment, visual loss or symptoms (floaters and photopsia) less than 30 days
Exclusion Criteria:
- No patient had a retinal break greater than 30 degrees, or retinal detachment larger than two quadrants, history of uveitis or infectious retinopathy, presence of Proliferative vitreoretinopathy (B or C), macular disease, glaucoma, hemoglobinopathy, diabetic retinopathy, and history of trauma or previous vitreoretinal surgery.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Cryopexy
laser photocoagulation 4 weeks after
the cryopexy was performed by placement of a normal spherical probe under the bucklings, around the break. The number of cryo applications was limited in number of 3. Freezing was stopped at the beginning of retinal whitening.
Laser-retinopexy was performed after proper positioning the patients; laser energy was delivered by depressing a foot pedal. Short burn duration (0.1 seconds) and low (300-miliWatts) power settings were used initially, and both the burn duration and power were gradually increased as determined by observation.